Skip to main content
brightpeptides

SKIN & AESTHETICS RESEARCH / FAQ

Questions From the Research Record

Direct, citation-anchored answers to the questions readers most often bring to GHK-Cu and Melanotan II.

What does a GHK-Cu peptide do?

GHK-Cu is a copper-binding tripeptide that, applied to skin, prompts fibroblasts to make more collagen, elastin and other matrix proteins while helping cross-link them into a firmer structure. Published reviews report topical GHK-Cu increased collagen production in 70% of treated subjects, versus 50% for vitamin C and 40% for retinoic acid [4]. It has also been studied, in a related combination formulation, for hair regrowth [3].

What is GHK-Cu and how does it work?

GHK-Cu is glycyl-L-histidyl-L-lysine chelated to a copper(II) ion — a fragment that occurs naturally in human collagen and is released when tissue is damaged. It works by activating fibroblasts and other skin cells to synthesize more collagen, elastin and glycosaminoglycans, while its copper component supports the enzyme that cross-links those fibers together and adds mild antioxidant activity [2][7].

Is GHK-Cu peptide really anti-aging?

The published evidence supports specific, modest anti-aging effects rather than a sweeping claim. Small controlled and in vitro studies document increased collagen synthesis, improved skin firmness and reduced fine-line depth with topical use [1][4], but human trials are small, and native GHK has poor skin penetration, which limits how much of any product's active ingredient reaches living tissue [1]. It is best read as one well-studied contributor to skin structure, not a proven cure for aging.

What is the difference between GHK and GHK-Cu?

GHK is the bare tripeptide (glycine-histidine-lysine); GHK-Cu is that same peptide bound to a copper ion. The distinction matters because most of the documented tissue-remodeling activity in the research literature depends on the copper being properly bound — plain GHK without copper does not reproduce key laboratory effects, which is why the cosmetic and research literature specifically studies the copper-chelated form.

What is Melanotan 2?

Melanotan II is a synthetic, cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), engineered in the late 1980s to be more potent and longer-lasting than the natural hormone. It is not approved by the FDA or any other regulator for any use [11].

What is Melanotan 2 used for in research?

In published research, Melanotan II has been studied for its effects on skin pigmentation, appetite and sexual function. The only placebo-controlled human trial tested it for erectile dysfunction in 10 men, where it produced significantly longer erections than placebo [12]; a 2022 mouse study found it reduced food intake and food-motivated behavior via receptors in the brain's reward circuitry [9]. No completed trial has studied it specifically as a tanning agent.

How does Melanotan 2 work in the body?

It acts as a non-selective agonist across the melanocortin receptor family. On skin cells, activating MC1R triggers a signaling cascade that switches on melanin production, darkening skin without UV exposure. The same molecule also activates MC3R and MC4R in the brain, which is why it independently affects appetite and sexual arousal — one compound acting on several unrelated systems at once.

What is the melanogenesis (MC1R-cAMP-MITF) signaling cascade?

It's the chain of chemical signals inside a pigment cell (melanocyte) that leads to more melanin. Activating the MC1R receptor raises intracellular cAMP, which activates protein kinase A (PKA); PKA in turn activates a transcription factor called CREB, which switches on the MITF gene — the master regulator of melanocyte activity. MITF then upregulates tyrosinase, the enzyme that actually builds melanin and shifts production toward the darker eumelanin form. Melanotan II drives this entire cascade by strongly activating the MC1R receptor at the top of the chain.

Are GHK-Cu and Melanotan II safe?

Not equally. Topical GHK-Cu, sold as Copper Tripeptide-1, has a long cosmetic safety record, with irritation as its main reported downside; injectable or systemic use is unapproved and essentially unstudied in humans. Melanotan II carries a materially different profile: published case reports document kidney injury, priapism and new or changing moles associated with its use [10], and because it is sold entirely unregulated online, the identity and purity of any given product cannot be verified. Neither compound is evaluated here for use in a specific individual — that judgment belongs to a licensed clinician.